Test Price
2,800 AEDโ Home Collection Available
LINS1 Gene Sequencing (NGS) for Intellectual Disability Type 27 in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Key Performance Indicators
- Diagnostic Accuracy: 99.9% sensitivity and specificity across all coding and splice-site regions via ISO-certified NGS processing (Certificate No. INT/EGQ/2509DA/3139).
- Logistics Excellence: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM, ensuring hospital-grade sample integrity.
- Clinical Support: Dedicated post-test tele-consultation with a consultant medical geneticist to guide result interpretation and family planning.
- Insurance Verification: Direct benefit validation via WhatsApp at +971 54 548 8731 prior to sample collection.
Test Overview & Methodology
The LINS1 gene sequencing assay employs next-generation sequencing (NGS) technology to interrogate the complete coding region and conserved splice-site junctions of the LINS1 gene. This approach identifies pathogenic and likely pathogenic variants associated with autosomal recessive intellectual disability type 27, enabling a definitive molecular diagnosis for affected individuals and informing recurrence risk for families. The Illumina platform delivers 100x average coverage depth, ensuring robust detection of single-nucleotide variants and small insertions or deletions across all exons.
| Parameter | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Technology | NGS (Illumina platform, 100x coverage) | Sanger sequencing (single amplicon per reaction) |
| Detection Rate | >99% of coding and splice-site variants | Limited to targeted exons; may miss deep intronic or mosaic variants |
| Turnaround Time | 21โ28 business days | 28โ42 business days (sequential gene testing may be required) |
| Clinical Utility | Comprehensive molecular diagnosis, carrier testing, and recurrence risk counselling | May require multiple ordered tests, increasing cumulative time and cost |
Physician Insight & Safety Protocols
โGenetic testing for intellectual disability often raises profound questions for families. This NGS panel offers a precise molecular diagnosis, but results must always be contextualised within a full neurodevelopmental assessment and multidisciplinary evaluation. A negative finding does not exclude other genetic or environmental causes, and family counselling should accompany every test report.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Advisory โ Medication and Clinical Management
โ ๏ธ Never discontinue or modify prescribed therapies, including antiepileptic or behavioural medications, without direct consultation with your treating neurologist or paediatrician. Abrupt cessation may precipitate seizure recurrence or clinical decompensation.
Exclusion Criteria & Clinical Red Flags
- Exclusion: Active febrile illness at time of collection, blood transfusion within 90 days, or inability to obtain informed consent from a legal guardian for minors (guardian consent is mandatory per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Red Flags: Acute onset of seizures, loss of consciousness, rapid behavioural regression, or signs of elevated intracranial pressure (persistent headache, vomiting, blurred vision) โ immediate emergency care is required.
Patient FAQ & Clinical Guidance
1. What does a positive LINS1 gene result mean for my family?
A positive result confirms a molecular diagnosis of autosomal recessive intellectual disability type 27. This allows neurologists, genetic counsellors, and allied health professionals to tailor early interventions โ including speech therapy, occupational therapy, and educational support โ and to calculate recurrence risk for siblings and future pregnancies.
2. How is the blood sample collected and transported?
A trained phlebotomist visits your home or office during a VIP mobile appointment (daily 8 AM โ 11 PM) to draw a small volume of peripheral whole blood. The specimen is immediately placed in a temperature-controlled cold-chain package and couriered to our ISO-certified laboratory for DNA extraction and NGS analysis.
3. Will my UAE health insurance cover this genetic test?
Most UAE health insurers cover diagnostic genetic testing when deemed medically necessary by a physician. Our team performs a complimentary benefit verification via WhatsApp at +971 54 548 8731 before sample collection, so you will know your coverage in advance with no financial surprise.
UAE Regulatory & Data Privacy Adherence
All genetic testing and associated data handling at DNA Labs UAE strictly comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient genomic information is encrypted, access-controlled, and never shared with third parties without explicit written consent. Clinical safety and informed consent procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | LINS1 Gene Sequencing (NGS) for Intellectual Disability Type 27 |
| Price (AED) | 2,800 AED |
| Turnaround Time | 21โ28 Business Days |
| Sample Type / Matrix | Peripheral Whole Blood โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next-Generation Sequencing (NGS) โ Illumina Platform, 100x Average Coverage |
| ICD-10-CM Code | F78 |
| LOINC Code | 81251-6 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians